banner

News Releases

None | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
Date Title
07/21/21
The New England Journal of Medicine Publishes Results from the Phase 3 HARMONY Study Evaluating Pimavanserin in Patients with Dementia-Related Psychosis
07/21/21
Acadia Pharmaceuticals to Announce Second Quarter 2021 Financial Results on August 4, 2021
07/14/21
Acadia Pharmaceuticals to Present New Scientific Data on Pimavanserin in Neurodegenerative Diseases at the Alzheimer’s Association International Conference 2021 (AAIC)
06/03/21
NUPLAZID® (pimavanserin) Efficacy Data from Open-Label Extension (OLE) Study Published in Parkinsonism and Related Disorders
05/26/21
Acadia Pharmaceuticals to Present at Upcoming Investor Conferences
05/05/21
Acadia Pharmaceuticals Reports First Quarter 2021 Financial Results
05/04/21
Acadia Pharmaceuticals to Present at Upcoming Investor Conferences
04/21/21
Acadia Pharmaceuticals to Announce First Quarter 2021 Financial Results on May 5, 2021
04/05/21
Acadia Pharmaceuticals Receives Complete Response Letter from U.S. FDA for Supplemental New Drug Application for Pimavanserin for the Treatment of Hallucinations and Delusions Associated with Dementia-Related Psychosis
03/08/21
Acadia Pharmaceuticals Provides Regulatory Update on Supplemental New Drug Application for Pimavanserin for the Treatment of Hallucinations and Delusions Associated with Dementia-Related Psychosis
02/24/21
Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
02/19/21
Acadia Pharmaceuticals Recognizes National Caregiver’s Day with Launch of MoreThanMemoryLoss.com
02/18/21
Acadia Pharmaceuticals to Present at Upcoming Investor Conferences
02/10/21
Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021
01/27/21
Acadia Pharmaceuticals Announces Commercial Leadership Change